Matthew Schissler, an entrepreneur and private investor with decades of experience across biotech and private equity, challenges conventional definitions of success and net worth, emphasizing that real value extends far beyond financial statements. "I've never believed value begins or ends with money," Schissler states. "Net worth means nothing if there's no purpose behind it." This philosophy has guided his career, from founding Cord Blood America, Inc. in 2003 to his current management of private investment funds.
Schissler's approach centers on building lasting enterprises rather than pursuing quick profits. At Cord Blood America, he led expansion through acquisitions and international partnerships, helping establish cord blood banking as a viable option for families globally. However, he notes that revenue growth was never the sole objective. "You can grow a business for numbers, or you can grow it because you believe in the outcome," he explains. "The numbers follow. But the mission has to lead." This mindset informs his investment strategy, which focuses on fundamentals, real value propositions, and leadership teams committed to long-term building.
Since 2015, Schissler has managed private investment funds targeting high-potential companies in overlooked markets. He is also the founder of Work Your Core Investments, a fund dedicated to fitness franchises and performance-driven business models. His work consistently prioritizes growth that serves a larger purpose. "I've worked with founders who wanted to flip something fast. I've also worked with founders who wanted to create something lasting. I'll take the second kind every time," he says. For Schissler, net worth is merely a snapshot in time, not an ultimate goal.
His commitment to purpose-driven value is evident in his board service, which includes roles with organizations like Aztec Airways, a regional airline connecting South Florida to the Bahamas, and nonprofits such as the Las Vegas Natural History Museum. He has also led advisory efforts in Nevada's biotech sector. Schissler emphasizes that these positions are about alignment, not prestige. "When I join something, it's because I see a reason to help," he says. "Not because I need another line on a resume."
Schissler's career, marked by risks and setbacks, has reinforced his belief that true worth is tested in challenging moments. "Anyone can look successful on paper. But when things don't go to plan, you find out who's really invested in what they're building," he observes. He defines wealth not by assets but by actions: "It's not what you have. It's what you keep showing up for. It's how you lead when no one's watching. It's how you treat people when there's nothing to gain."
In an era where financial metrics often dominate business discourse, Schissler's perspective offers a counterpoint, highlighting the importance of reputation, consistency, and contribution. "Money is a tool," he concludes. "Use it well, and it creates space to focus on what really matters. But if you treat it like a scoreboard, you'll miss everything that counts." As he continues to manage investments and advise companies, Schissler remains focused on supporting ideas, people, and businesses that reflect deeper values, asserting that "real value isn't built overnight. It's earned, over time, by how you live."
